MIF: a new cytokine link between rheumatoid arthritis and atherosclerosis

Nature Reviews. Drug Discovery
Eric F MorandJ Bernhagen

Abstract

Macrophage migration inhibitory factor (MIF) is well established as a key cytokine in immuno-inflammatory diseases such as rheumatoid arthritis. Inflammation is now also recognized as having a crucial role in atherosclerosis, and recent evidence indicates that MIF could also be important in this disease. Here, we review the role of MIF in rheumatoid arthritis and atherosclerosis, discuss the ways in which MIF and its relationship with glucocorticoids could link these diseases, and consider the potential of MIF as a new therapeutic target for small-molecule and antibody-based anti-cytokine drugs.

References

Jun 1, 1990·Journal of the American College of Cardiology·J H IpJ H Chesebro
Jul 1, 1966·Proceedings of the National Academy of Sciences of the United States of America·J R David
Jul 23, 1996·Proceedings of the National Academy of Sciences of the United States of America·M BacherR Bucala
Jan 1, 1997·Arteriosclerosis, Thrombosis, and Vascular Biology·M KusuharaB C Berk
Jan 14, 1999·The New England Journal of Medicine·R Ross
Feb 3, 1999·Proceedings of the National Academy of Sciences of the United States of America·F S Dhabhar, B S McEwen
Nov 24, 1999·The Journal of Experimental Medicine·J D HudsonD H Beach
Sep 23, 2000·Nature·A J Lusis
Oct 29, 2000·Annals of the Rheumatic Diseases·M FeldmannR N Maini
Mar 22, 2001·EMBO Reports·D A Chamovitz, D Segal
Nov 2, 2001·Atherosclerosis·N Hurwitz EllerA M Hansen
Jan 5, 2002·Proceedings of the National Academy of Sciences of the United States of America·Robert A MitchellRichard Bucala
Jan 5, 2002·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Jerome GalonStefan R Bornstein
Jan 5, 2002·Proceedings of the National Academy of Sciences of the United States of America·Peter D SenterRichard Bucala

❮ Previous
Next ❯

Citations

Aug 24, 2012·The Proceedings of the Nutrition Society·Orla M FinucaneHelen M Roche
Mar 26, 2009·Accounts of Chemical Research·William L Jorgensen
Dec 19, 2008·Journal of Medicinal Chemistry·Zoe CourniaWilliam L Jorgensen
Oct 23, 2008·Nano Letters·David P CormodeWillem J M Mulder
May 9, 2012·Cell Research·Omar El Bounkari, Jürrgen Bernhagen
Oct 31, 2007·Nature Clinical Practice. Rheumatology·Zoltán Szekanecz, Alisa E Koch
Feb 1, 2008·Nature Clinical Practice. Rheumatology·Sally AyoubEric F Morand
Feb 2, 2010·Nature Reviews. Drug Discovery·Rory R Koenen, Christian Weber
May 26, 2007·Nature Reviews. Immunology·Iain B McInnes, Georg Schett
Sep 7, 2007·The New England Journal of Medicine·Elaine F RemmersPeter K Gregersen
Oct 15, 2008·Proceedings of the National Academy of Sciences of the United States of America·Christian WeberJürgen Bernhagen
Oct 5, 2011·Proceedings of the National Academy of Sciences of the United States of America·Daniel HeinrichsHermann E Wasmuth
Jul 12, 2012·The Journal of Biological Chemistry·Fengwei BaiKaren G Anthony
Jan 22, 2009·The Journal of Biological Chemistry·Ana-Maria FilipAndreas Meinhardt
Mar 12, 2010·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·James M HarperRichard A Miller
Apr 7, 2007·Current Opinion in Rheumatology·Zoltán Szekanecz, Alisa E Koch
Apr 7, 2007·Current Opinion in Rheumatology·Eric F Morand
Mar 23, 2010·Current Opinion in Rheumatology·Zoltán SzekaneczAlisa E Koch
Jun 25, 2010·Clinical and Experimental Pharmacology & Physiology·Jia-Liang LiangXi-Yong Yu
Jun 29, 2010·American Journal of Respiratory and Critical Care Medicine·Douglas ArenbergAlisa E Koch
Aug 2, 2012·Therapeutic Advances in Musculoskeletal Disease·Jonathan L Marks, Christopher J Edwards
May 6, 2009·Respiratory Research·Koichiro TakahashiEdmund J Miller
Jul 16, 2009·BMC Cancer·Eva VerjansJürgen Bernhagen
Aug 26, 2009·Journal of Inflammation·Elliott TarantoMichelle Leech
Oct 25, 2008·Arthritis Research & Therapy·Stefan K DrexlerBrian M Foxwell
Oct 10, 2008·Journal of the American Society of Nephrology : JASN·Maria Dolores Sanchez-NiñoAlberto Ortiz

❮ Previous
Next ❯

Related Concepts

Related Feeds

Anti-Arrhythmic Drug Therapies

Anti-arrhythmic drugs are used to prevent abnormal heart rhythms. These medications are used in conditions including, ventricular tachycardia, ventricular fibrillation and atrial fibrillation. Discover the latest research on anti-arrhythmic drug therapies here.

Atherosclerosis Disease Progression

Atherosclerosis is the buildup of plaque on artery walls, causing stenosis which can eventually lead to clinically apparent cardiovascular disease. Find the latest research on atherosclerosis disease progression here.